Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.
SOURCE Microsoft Corp.
Provider of patient-driven eData Systems will run data collection system on Dell Venue 11 Pro tablets with Windows 8.1.
REDMOND, Wash., June 17, 2014 /PRNewswire/ -- PHT Corporation, the leading provider of technologies used to collect patient-driven electronic data for clinical research, has selected Dell Venue 11 Pro tablets featuring Windows 8.1 to run its SitePad® System. The SitePad System replaces traditional paper data collection methods in clinical research with electronic methods, providing better-quality data, real-time access to that data and, ultimately, faster time to data analysis for pharmaceutical trial sponsors. The SitePad System is used in clinical trials to collect clinician- and patient-reported outcomes for supporting label claims of new therapies.
PHT selected the Dell Venue 11 Pro with Windows 8.1 for the SitePad platform because the device provides a superior user experience. The Venue has a high-resolution touch screen that supports greater ease of use for both clinicians and patients. In addition to providing a superior user experience, the Dell Venue provides multiple modes of data communications including Wi-Fi, Ethernet and an embedded 4G card.
PHT chose the Windows 8.1 tablets because of the flexibility and security aspects of Microsoft technology and because the solution allows PHT to increase the quality of real-time site-based data capture for trial participants and clinicians. It also allows PHT to run custom software that helps decrease clinical trial costs for sponsors by reducing time spent downstream resolving missing and inconsistent data. The superior end-user experience helps provide additional convenience and comfort for end users, enabling rapid entry of electronic source clinical data.
"Paper is no longer the gold standard, and clinical trial sponsors are rapidly abandoning paper methods for collecting critical information about how patients feel and function in addition to key clinician observations and assessments," said Sheila Rocchio, vice president of Marketing & Product Management at PHT. "PHT is helping to lead the electronic transformation in clinical research by providing reliable, easy-to-use and regulatory-compliant systems that increase data quality and protocol compliance and reduce costs in monitoring and data management. In one recent trial, the SitePad System saved the sponsor more than 30 percent over the cost of paper."
PHT has purchased more than 2,000 Dell Venue 11 Pros, which will be deployed at clinical trial sites around the globe. Each SitePad is configured for a specific study protocol and used by clinicians and patients participating in the trial to collect study-specific assessments. Data collected on the SitePad device are sent to StudyWorks™, the PHT online portal that provides real-time information about compliance as well as key measures used for study operations and patient safety monitoring. Each tablet is preconfigured with study-specific schedules, assessments and questionnaires. Patient and clinician compliance with SitePad on average exceeds 98.5 percent.
"The Dell Venue 11 Pro with Windows 8.1 is a modern and sleek device that both patients and clinicians enjoy using - the usability testing feedback has been excellent," Rocchio said. "Sponsors are also very excited about the embedded 4G modem in the Dell Venue 11 Pro, which eliminates the need for an additional wireless hotspot, making setup much easier."
More information about how organizations are turning to Microsoft technology is available on the Microsoft Customer Spotlight newsroom.
About PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices. PHT scientific, regulatory and technological expertise combined with quality outcomes data enable clients to make decisions with confidence. Sponsors and CROs have leveraged the PHT Patient Suite in 650+ trials resulting in 16+ regulatory approvals. Visit phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Facebook, Twitter, Google+ and YouTube.
Founded in 1975, Microsoft (Nasdaq "MSFT") is the worldwide leader in software, services, devices and solutions that help people and businesses realize their full potential.
©2012 PR Newswire. All Rights Reserved.